{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:09:54Z","timestamp":1789610994452,"version":"build-2803163510"},"reference-count":72,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:00:00Z","timestamp":1496016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression by binding to the 3\u2019-UTR of their target genes, can act as oncogenes or tumor suppressors. Recently, other types of non-coding RNAs\u2014piwiRNAs and long non-coding RNAs\u2014have also been identified. Hodgkin lymphoma (HL) is a B cell origin disease characterized by the presence of only 1% of tumor cells, known as Hodgkin and Reed-Stenberg (HRS) cells, which interact with the microenvironment to evade apoptosis. Several studies have reported specific miRNA signatures that can differentiate HL lymph nodes from reactive lymph nodes, identify histologic groups within classical HL, and distinguish HRS cells from germinal center B cells. Moreover, some signatures are associated with survival or response to chemotherapy. Most of the miRNAs in the signatures regulate genes related to apoptosis, cell cycle arrest, or signaling pathways. Here we review findings on miRNAs in HL, as well as on other non-coding RNAs.<\/jats:p>","DOI":"10.3390\/ijms18061154","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T04:35:42Z","timestamp":1496118942000},"page":"1154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Non-Coding RNAs in Hodgkin Lymphoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-1259","authenticated-orcid":false,"given":"Anna","family":"Cordeiro","sequence":"first","affiliation":[{"name":"Molecular Oncology and Embryology Laboratory, Human Anatomy and Embryology Unit, School of Medicine, University of Barcelona, C\/Casanova 143, 08032 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Monz\u00f3","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Embryology Laboratory, Human Anatomy and Embryology Unit, School of Medicine, University of Barcelona, C\/Casanova 143, 08032 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6071-0926","authenticated-orcid":false,"given":"Alfons","family":"Navarro","sequence":"additional","affiliation":[{"name":"Molecular Oncology and Embryology Laboratory, Human Anatomy and Embryology Unit, School of Medicine, University of Barcelona, C\/Casanova 143, 08032 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/095952873201700106","article-title":"On some morbid appearances of the absorbent glands and spleen","volume":"17","author":"Hodgkin","year":"1832","journal-title":"Med. Chir. Trans."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant hodgkin lymphoma","volume":"4","author":"Schmitz","year":"2009","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 who classification of lymphoid neoplasms and beyond: Evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised european-american classification of lymphoid neoplasms","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nri3814","article-title":"Germinal centres and B cell lymphomagenesis","volume":"15","author":"Basso","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and reed-sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/jcp.55.3.162","article-title":"Hodgkin\u2019s lymphoma: The pathologist\u2019s viewpoint","volume":"55","author":"Pileri","year":"2002","journal-title":"J. Clin. Pathol."},{"key":"ref_9","first-page":"58","article-title":"Epstein-barr virus and the origin of hodgkin lymphoma","volume":"57","author":"Vockerodt","year":"2014","journal-title":"Cell Differ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molonc.2011.10.003","article-title":"Non-coding RNAs in cancer initiation and progression and as novel biomarkers","volume":"5","author":"Croce","year":"2011","journal-title":"Mol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","article-title":"Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans","volume":"75","author":"Wightman","year":"1993","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/138920210790217918","article-title":"Small RNA diversity in plants and its impact in development","volume":"11","author":"Sorin","year":"2010","journal-title":"Curr. Genom."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs","volume":"304","author":"Pfeffer","year":"2004","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1126\/science.1080372","article-title":"Vertebrate microRNA genes","volume":"299","author":"Lim","year":"2003","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1261\/rna.2248605","article-title":"MicroRNA function: Multiple mechanisms for a tiny RNA?","volume":"11","author":"Pillai","year":"2005","journal-title":"RNA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"Bic and miR-155 are highly expressed in hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/gcc.10186","article-title":"High expression of B-cell receptor inducible gene bic in all subtypes of hodgkin lymphoma","volume":"37","author":"Kroesen","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of mir-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","article-title":"MicroRNA expression profiling in classic hodgkin lymphoma","volume":"111","author":"Navarro","year":"2008","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Jones, K., Nourse, J.P., Keane, C., Bhatnagar, A., and Gandhi, M.K. Plasma microRNA are disease response biomarkers in classical hodgkin lymphoma. Clin. Cancer Res., 2013.","DOI":"10.1158\/1078-0432.CCR-13-1024"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2009.07909.x","article-title":"Comparison of miRNA profiles of microdissected hodgkin\/reed-sternberg cells and hodgkin cell lines versus cd77+b-cells reveals a distinct subset of differentially expressed miRNAs","volume":"147","author":"Mestdagh","year":"2009","journal-title":"Br. J Haematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"167IN166","DOI":"10.1593\/neo.08980","article-title":"Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile","volume":"11","author":"Gibcus","year":"2009","journal-title":"Neoplasia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/bjh.12390","article-title":"MICRORNA signatures and treatment response in patients with advanced classical hodgkin lymphoma","volume":"162","author":"Figueroa","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-016-0749-5","article-title":"Micro-RNA (miRNA) profile in hodgkin lymphoma: Association between clinical and pathological variables","volume":"33","author":"Paydas","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature09284","article-title":"Oncomir addiction in an in vivo model of microRNA-21-induced pre-b-cell lymphoma","volume":"467","author":"Medina","year":"2010","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing primary hodgkin and reed-sternberg cells to capture the molecular and cellular pathogenesis of classical hodgkin lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood-2009-02-204842","article-title":"Regulation of jak2 by miR-135a: Prognostic impact in classic hodgkin lymphoma","volume":"114","author":"Navarro","year":"2009","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Van Den Berg, A.V., Vidal, F., Cruz, A.M.P., and Ribeiro-dos-Santos, \u00c2. MicroRNAs as biomarkers of the response to treatment with abvd scheme in hodgkin lymphoma. J. Leukemia, 2015.","DOI":"10.4172\/2329-6917.1000200"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Van Eijndhoven, M.A., Zijlstra, J.M., Groenewegen, N.J., Drees, E.E., van Niele, S., Baglio, S.R., Koppers-Lalic, D., van der Voorn, H., Libregts, S.F., and Wauben, M.H. Plasma vesicle miRNAs for therapy response monitoring in hodgkin lymphoma patients. JCI Insight, 2016.","DOI":"10.1172\/jci.insight.89631"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"46002","DOI":"10.18632\/oncotarget.10015","article-title":"PiwiRNA-651 as marker of treatment response and survival in classical hodgkin lymphoma","volume":"7","author":"Cordeiro","year":"2016","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.18632\/oncotarget.6165","article-title":"Inhibition of the miR-155 target niam phenocopies the growth promoting effect of miR-155 in B-cell lymphoma","volume":"7","author":"Kluiver","year":"2016","journal-title":"Oncotarget"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2009-05-220814","article-title":"Src homology 2 domain\u2013containing inositol-5-phosphatase and CCAAT enhancer-binding protein \u03b2 are targeted by mir-155 in B cells of e\u03bc-miR-155 transgenic mice","volume":"114","author":"Costinean","year":"2009","journal-title":"Blood"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in e\u03bc-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","article-title":"Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma","volume":"109","author":"Babar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2353\/ajpath.2008.080009","article-title":"MicroRNA-mediated down-regulation of prdm1\/blimp-1 in hodgkin\/reed-sternberg cells: A potential pathogenetic lesion in hodgkin lymphomas","volume":"173","author":"Nie","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1074-7613(02)00335-7","article-title":"Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program","volume":"17","author":"Shaffer","year":"2002","journal-title":"Immunity"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E382","DOI":"10.1002\/ijc.26503","article-title":"Cd99 triggers upregulation of miR-9-modulated prdm1\/blimp1 in hodgkin\/reed\u2013sternberg cells and induces redifferentiation","volume":"131","author":"Huang","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1182\/blood.V92.11.4287","article-title":"Generation of cells with Hodgkin\u2019s and reed-sternberg phenotype through downregulation of cd99 (mic2)","volume":"92","author":"Kim","year":"1998","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/blood.V95.1.294","article-title":"Viral latent membrane protein 1 (lmp-1)\u2013induced cd99 down-regulation in b cells leads to the generation of cells with Hodgkin\u2019s and reed-sternberg phenotype","volume":"95","author":"Kim","year":"2000","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1038\/onc.2012.15","article-title":"Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo","volume":"31","author":"Leucci","year":"2012","journal-title":"Oncogene"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00431-015-2660-z","article-title":"Hodgkin lymphoma as a novel presentation of familial DICER1 syndrome","volume":"175","author":"Kuhlen","year":"2016","journal-title":"Eur. J. Pediatr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/MCB.01977-07","article-title":"MicroRNAs in the miR-106b family regulate p21\/CDKN1A and promote cell cycle progression","volume":"28","author":"Ivanovska","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/nar\/gkp715","article-title":"A high throughput experimental approach to identify miRNA targets in human cells","volume":"37","author":"Tan","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/path.2958","article-title":"MiR-17\/106b seed family regulates p21 in Hodgkin\u2019s lymphoma","volume":"225","author":"Gibcus","year":"2011","journal-title":"J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V122.21.629.629","article-title":"Prognostic significance of a 4-microRNA signature targeting jak2 in classical hodgkin lymphoma","volume":"122","author":"Navarro","year":"2013","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2011-09-381905","article-title":"Foxo1 is a tumor suppressor in classical hodgkin lymphoma","volume":"119","author":"Xie","year":"2012","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1182\/blood-2014-07-590570","article-title":"Foxo1 repression contributes to block of plasma cell differentiation in classical hodgkin lymphoma","volume":"124","author":"Vogel","year":"2014","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000432402","article-title":"Investigation of miR9-1, miR9-2 and miR9-3 methylation in hodgkin lymphoma","volume":"82","author":"Ziadi","year":"2015","journal-title":"Pathobiology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.3109\/10428194.2014.995650","article-title":"Epigenetic regulation of microRNA expression in hodgkin lymphoma","volume":"56","author":"Navarro","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-06-4218","article-title":"Genetic unmasking of an epigenetically silenced microRNA in human cancer cells","volume":"67","author":"Lujambio","year":"2007","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V73.8.2149.2149","article-title":"Chromosomal abnormalities in Hodgkin\u2019s disease","volume":"73","author":"Schouten","year":"1989","journal-title":"Blood"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","article-title":"Detection of genomic imbalances in microdissected hodgkin and reed-sternberg cells of classical Hodgkin\u2019s lymphoma by array-based comparative genomic hybridization","volume":"93","author":"Hartmann","year":"2008","journal-title":"Haematologica"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary hodgkin and reed-sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1080\/10428194.2016.1177179","article-title":"Recurrent genetic defects in classical hodgkin lymphoma cell lines","volume":"57","author":"Hudnall","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4161\/cc.7.7.5666","article-title":"Mirsnps or miR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics","volume":"7","author":"Mishra","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Navarro, A., Munoz, C., Gaya, A., D\u00edaz-Bey\u00e1, M., Gel, B., Tejero, R., D\u00edaz, T., Martinez, A., and Monzo, M. (2013). MiR-SNPs as markers of toxicity and clinical outcome in hodgkin lymphoma patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064716"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: Insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"31613","DOI":"10.18632\/oncotarget.5148","article-title":"The lincRNA hotairm1, located in the hoxa genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature","volume":"6","author":"Brunet","year":"2015","journal-title":"Oncotarget"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/srep02535","article-title":"MicroRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus","volume":"3","author":"Leucci","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.2174\/1381612821666150724115625","article-title":"Long noncoding RNA MALAT1: Insights into its biogenesis and implications in human disease","volume":"21","author":"Wu","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ajpath.2016.05.011","article-title":"Long noncoding RNA expression profiling in normal B-cell subsets and hodgkin lymphoma reveals hodgkin and reed-sternberg cell-specific long noncoding RNAs","volume":"186","author":"Tayari","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-biochem-060614-034258","article-title":"Piwi-interacting RNA: Its biogenesis and functions","volume":"84","author":"Iwasaki","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.cca.2011.05.015","article-title":"PiRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells","volume":"412","author":"Cheng","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s12094-012-0966-0","article-title":"Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer","volume":"15","author":"Huang","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jhep.2013.01.032","article-title":"Deep sequencing of small RNA transcriptome reveals novel non-coding RNAs in hepatocellular carcinoma","volume":"58","author":"Law","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/leu.2014.135","article-title":"PiRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma","volume":"29","author":"Yan","year":"2015","journal-title":"Leukemia"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.clinbiochem.2011.06.004","article-title":"Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as markers","volume":"44","author":"Cui","year":"2011","journal-title":"Clin. Biochem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/6\/1154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:37:20Z","timestamp":1760207840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/6\/1154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":72,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6]]}},"alternative-id":["ijms18061154"],"URL":"https:\/\/doi.org\/10.3390\/ijms18061154","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]}}}